SCHEMBL13902844

SCHEMBL13902844

CCCOc1ccc(C#CCCCO)cc1C(=O)NC(CO)Cc1c[nH]c2ccc(F)cc12

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.39
HTR1A P08908 3/20 0.39
ADAM17 P78536 1/20 0.39
CCKBR P32239 2/20 0.37
MPO P05164 7/20 0.37
HTR2A P28223 2/20 0.36
SCN8A Q9UQD0 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.36
ITGB2 P05107 1/20 0.36
ICAM1 P05362 1/20 0.36
ITGAL P20701 1/20 0.36
HTR2C P28335 1/20 0.36
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
NOTUM Q6P988 1/20 0.35
LTB4R Q15722 1/20 0.35
SPR P35270 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3941230 1.00 SLC6A4 (0.39) SLC6A4HTR1AADAM17CCKBRMPO
SCHEMBL13902842 0.95 ADAM17 (0.39) SLC6A4HTR1AADAM17CCKBRMPO
SCHEMBL3937227 0.95 ADAM17 (0.39) SLC6A4HTR1AADAM17CCKBRMPO
SCHEMBL13902843 0.94 MPO (0.41) SLC6A4HTR1AADAM17CCKBRMPO
SCHEMBL3937035 0.94 MPO (0.41) SLC6A4HTR1AADAM17CCKBRMPO
SCHEMBL3934212 0.92 HTR1A (0.40) SLC6A4HTR1AADAM17CCKBRMPO
SCHEMBL13902839 0.92 HTR1A (0.40) SLC6A4HTR1AADAM17CCKBRMPO
SCHEMBL13902849 0.92 MPO (0.46) SLC6A4HTR1AADAM17CCKBRMPO
SCHEMBL3934460 0.92 MPO (0.46) SLC6A4HTR1AADAM17CCKBRMPO
SCHEMBL3938249 0.91 MPO (0.43) SLC6A4HTR1AADAM17CCKBRMPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090075987-A1 ALKYLACETYLENE SUBSTITUTED ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2009-03-19 US disclosed
US-20090075987-A1 ALKYLACETYLENE SUBSTITUTED ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AG (DE) 2009-03-19 US disclosed
WO-2009013333-A1 ALKYLACETYLENE SUBSTITUTED ACYLTRYPTOPHANOLS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-01-29 WO disclosed
EP-2019102-A1 Alkylacetylene substituted Acyltryptophanols Bayer Schering Pharma AG (DE) 2009-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090075987-A1 ALKYLACETYLENE SUBSTITUTED ACYLTRYPTOPHANOLS FSHR, GNRHR, CYP19A1 SLC6A4 519/4885HTR1A 10/4885ADAM17 2814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.